Tirzepatide
Dual GIP / GLP-1 Agonist
from$50
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its combined action on glucose metabolism and satiety signaling. Each Allpointe batch is characterized and independently verified.
SKU: AP-TIRZ-10MG
- Purity
- ≥ 99% (HPLC verified)
- Format
- Lyophilized powder
- Sizes
- 10 – 60 mg
Research Applications
- Studied for dual GIP/GLP-1 receptor signaling
- Investigated for glucose and lipid metabolism
- Explored for appetite-regulation models
This product is supplied strictly for in-vitro laboratory research use only. It is not a drug, supplement, or therapeutic, has not been evaluated by the FDA, and is not intended for human or veterinary consumption, injection, or application.
Research Use Only
All content and product information presented on this website is intended for educational and informational purposes only. Products available through Allpointe Bio Research are sold strictly for laboratory research use only — specifically for in-vitro experiments conducted outside the body. These products are not drugs, supplements, or medications, and have not been evaluated or approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition. Under no circumstances should these materials be used for human or animal consumption, injection, or application. Any bodily introduction is a direct violation of federal law.
